Catechol-o-methyltransferase inhibitors : Clinical potential in the treatment of Parkinson's diseaseDINGEMANSE, J.Drug development research. 1997, Vol 42, Num 1, pp 1-25, issn 0272-4391Article

Effect of severe renal impairment on the pharmacokinetics and tolerability of the parenteral endothelin antagonist tezosentanVAN GIERSBERGEN, P. L. M; DINGEMANSE, J.International journal of clinical pharmacology and therapeutics. 2003, Vol 41, Num 6, pp 261-266, issn 0946-1965, 6 p.Article

Determination of the threshold for convulsions by direct cortical stimulationVOSKUYL, R. A; DINGEMANSE, J; DANHOF, M et al.Epilepsy research. 1989, Vol 3, Num 2, pp 120-129, issn 0920-1211Article

Pharmacokinetic-pharmacodynamic modeling of CNS drug effects: an overviewDINGEMANSE, J; DANHOF, M; BREIMER, D. D et al.Pharmacology & therapeutics (Oxford). 1988, Vol 38, Num 1, pp 1-52, issn 0163-7258Article

PHARMACOKINETICS AND BIOAVAILABILITY OF INTRAVENOUS, ORAL, AND RECTAL NITRAZEPAM IN HUMANSJOCHEMSEN R; HOGEN DOORN JJH; DINGEMANSE J et al.1982; JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS; ISSN 0090-466X; USA; DA. 1982; VOL. 10; NO 3; PP. 231-248; BIBL. 15 REF.Article

Tyramine pressor sensitivity in healthy subjects during combined treatment with moclobemide and selegilineKORN, A; WAGNER, B; MORITZ, E et al.European journal of clinical pharmacology. 1996, Vol 49, Num 4, pp 273-278, issn 0031-6970Article

Pharmacodynamics of tolerance development to the anesthetic and anticonvulsant effects of phenobarbital in ratsDINGEMANSE, J; HAMETER, B. M; DANHOF, M et al.Journal of pharmaceutical sciences. 1990, Vol 79, Num 3, pp 207-211, issn 0022-3549Article

Pharmacokinetics, pharmacodynamics and the pharmacokinetic/ pharmacodynamic relationship of zolpidem in healthy subjectsDE HAAS, S. L; SCHOEMAKER, R. C; VAN GERVEN, J. M. A et al.Journal of psychopharmacology (Oxford). 2010, Vol 24, Num 11, pp 1619-1629, issn 0269-8811, 11 p.Article

Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor metrifonate in patients with renal impairmentDINGEMANSE, J; HALABI, A; KLEINBLOESEM, C. H et al.Therapeutic drug monitoring. 1999, Vol 21, Num 3, pp 310-316, issn 0163-4356Article

Comparative single- and multiple-dose pharmacokinetics of levodopa and 3-O-methyldopa following a new dual-release and a conventional slow-release formulation of levodopa and benserazide in healthy subjectsGASSER, U. E; CREVOISIER, C; OUWERKERK, M et al.European journal of pharmaceutics and biopharmaceutics. 1998, Vol 46, Num 2, pp 223-228, issn 0939-6411Article

Integrated pharmacokinetics and pharmacodynamics of Ro 48-8684, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjectsVAN GERVEN, J. M. A; RONCARI, G; SCHOEMAKER, R. C et al.British journal of clinical pharmacology. 1997, Vol 44, Num 5, pp 487-493, issn 0306-5251Article

Diazepam reverses the effects of pentylenetetrtazole in rat pups by acting at type 2 benzodiazepine receptorsJOHNSTON, A. L; FILE, S. E; DINGEMANSE, J et al.Pharmacology, biochemistry and behavior. 1989, Vol 32, Num 3, pp 823-825, issn 0091-3057Article

Modification of the cardiovascular effects of ephedrine by the reversible monoamine oxidase A-inhibitor MoclobemideDINGEMANSE, J; GUENTERT, T; GIESCHKE, R et al.Journal of cardiovascular pharmacology. 1996, Vol 28, Num 6, pp 856-861, issn 0160-2446Article

Comparative pharmacodynamics of Ro 41-3696, a new hypnotic, and zolpidem after night-time administration to healthy subjectsDINGEMANSE, J; BURY, M; BOCK, J et al.Psychopharmacologia. 1995, Vol 122, Num 2, pp 169-174, issn 0033-3158Article

An update of recent moclobemide interaction dataDINGEMANSE, J.International clinical psychopharmacology. 1993, Vol 7, Num 3-4, pp 167-180, issn 0268-1315Conference Paper

Orexin Receptor Antagonism, a New Sleep-Promoting Paradigm: An Ascending Single-Dose StudyWith AlmorexantHOEVER, P; DE HAAS, S; WINKLER, J et al.Clinical pharmacology and therapeutics. 2010, Vol 87, Num 5, pp 593-600, issn 0009-9236, 8 p.Article

In vivo and in vitro disposition profile of tezosentan, an intravenous dual endothelin receptor antagonist, in humansTREIBER, A; VAN GIERSBERGEN, P. L. M; DINGEMANSE, J et al.Xenobiotica (London. Print). 2003, Vol 33, Num 4, pp 399-414, issn 0049-8254, 16 p.Article

Dual-release formulation, a novel principle in L-dopa treatment of Parkinson's diseaseDESCOMBES, S; BONNET, A. M; GASSER, U. E et al.Neurology. 2001, Vol 56, Num 9, pp 1239-1242, issn 0028-3878Article

Pronounced effect of caprylocaproyl macrogolglycerides on nasal absorption of IS-159, a peptide serotonin 1B/1D-receptor agonistDINGEMANSE, J; SOUBROUILLARD, C; PARIS, J et al.Clinical pharmacology and therapeutics. 2000, Vol 68, Num 2, pp 114-121, issn 0009-9236Article

Pharmacokinetic-pharmacodynamic modelling of the EEG effects of Ro 48-6791, a new short-acting benzodiazepine, in young and elderly subjectsDINGEMANSE, J; HÄUSSLER, J; HERING, W et al.British Journal of Anaesthesia. 1997, Vol 79, Num 5, pp 567-574, issn 0007-0912Conference Paper

Integrated pharmacokinetics and pharmacodynamics of Ro 48-6791, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjectsDINGEMANSE, J; VAN GERVEN, J. M. A; SCHOEMAKER, R. C et al.British journal of clinical pharmacology. 1997, Vol 44, Num 5, pp 477-486, issn 0306-5251Article

Determination of 3,4-dihydroxyphenylacetic acid and 5-hydroxyindoleacetic acid in human plasma by a simple and rapid high-performance liquid chromatography assayYEUNG, P. K. F; BUCKLEY, S. J; PEDDER, S. C. J et al.Journal of pharmaceutical sciences. 1996, Vol 85, Num 4, pp 451-453, issn 0022-3549Article

Multiple-dose clinical pharmacology of the catechol-O-methyl-transferase inhibitor tolcapone in elderly subjectsDINGEMANSE, J; JORGA, K; ZÜRCHER, G et al.European journal of clinical pharmacology. 1996, Vol 50, Num 1-2, pp 47-55, issn 0031-6970Article

Die perkutane Penetration von Amorolfin nach einmaliger topischer Applikation einer Amorolfin Creme = The cutaneous penetration of Amorolfin after a single topical application of an Amorolfin creamRONCARI, G; PONELLE, C; ZUMBRUNNEN, R et al.H + G. Zeitschrift für Hautkrankheiten. Supplement. 1993, Vol 68, Num 1, pp 39-42, issn 0342-9687Article

Interactions of moclobemide with concomitantly administered medication : evidence from pharmacological and clinical studiesAMREIN, R; GÜNTERT, T. W; DINGEMANSE, J et al.Psychopharmacologia. 1992, Vol 106, pp S24-S31, issn 0033-3158, SUPConference Paper